Furthermore, a research involving 241 CRC patients found that serum IL-13 levels were significantly lower in advanced cancer patients, and lower serum IL-13 levels were significantly associated with a poorer prognosis (21). The gene discussed is IL13; the disease is colorectal carcinoma.